7,9,10,13-tetrakis(acetyloxy)taxa-4(20),11-dien-5-yl (2E)-3-phenylprop-2-enoate (18457-46-0)

Identification
Name:	7,9,10,13-tetrakis(acetyloxy)taxa-4(20),11-dien-5-yl (2E)-3-phenylprop-2-enoate
Synonyms:	Cuspidatin C;NSC636859;NSC-636859;18457-46-0
CAS:	18457-46-0
Molecular Formula:	C₃₇H₄₆O₁₀
Molecular Weight:	650.7551
InChI:	InChI=1/C37H46O10/c1-20-28-17-27-18-29(43-22(3)38)21(2)33(36(27,7)8)34(45-24(5)40)35(46-25(6)41)37(28,9)31(44-23(4)39)19-30(20)47-32(42)16-15-26-13-11-10-12-14-26/h10-16,27-31,34-35H,1,17-19H2,2-9H3/b16-15+
Molecular Structure:
Properties
Flash Point:	273.8°C
Boiling Point:	673.8°C at 760 mmHg
Density:	1.21g/cm³
Refractive index:	1.553
Flash Point:	273.8°C
Safety Data

Other Product

(3xi,5alpha)-taxa-4(20),11-dien-5-yl acetate
(2alpha,5alpha,10alpha)-2,9,10-tris(acetyloxy)-13-oxotaxa-4(20),11-dien-5-yl (2Z)-3-phenylprop-2-enoate - N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-1H-imidazole-1-carboxamide (1:1)
10-(acetyloxy)-1,2,9-trihydroxy-13-oxotaxa-4(20),11-dien-5-yl 3-(dimethylamino)-3-phenylpropanoate
(3xi,5alpha)-taxa-4(20),11-dien-5-ol
18,19-Dinorpregna-5(10),9(11)-dien-20-yn-3-one,13-ethyl-17-hydroxy-, (17a)-
18,19-Dinorpregna-5(10),9(11)-dien-20-yn-3-one,13-ethyl-17-hydroxy-, cyclic 1,2-ethanediyl acetal, (17a)-
(4alpha,12xi)-8-oxo-12,13-epoxytrichothec-9-en-4-yl (2E)-3-phenylprop-2-enoate
1/C12H9NO/c14-9-11-3-1-2-4-12(11)10-5-7-13-8-6-10/h1-9
(3beta)-lup-20(29)-en-3-yl (2E)-3-phenylprop-2-enoate
(10E,12Z)-hexadeca-10,12-dien-1-yl (2E)-3-phenylprop-2-enoate
1/C11H7ClO2/c12-9-3-1-2-8(6-9)11-5-4-10(7-13)14-11/h1-7
Dispiro[furan-2(3H),2'(13'H)-bisfuro[3'',2'':3',4']- cyclopenta[1',2':5,6]naphtho[1,2-b:1',2'-i]- phenazine-13',2''-[2H]pyran]-5'',11',22'-triol,1',3'',3'a,4,4',4'',4'a,4'b,5,5',5'',6',6'',6'a,7',9',9'a,- 9'b,10',11',11'a,11'b,12',14'a,15'b,16',17',17'a,18',- 20',20'a,20'b,21',22',22'a,22'bhexatriacontahydro- 1',5,5,5'',9'a,11'a,12',20'a,- 22'a-nonamethyl-,(1'S,2R,2''R,3'aS,4'aR,4'bR,- 6''S,6'aS,9'aS,9'bS,11'R,11'aR,11'bR,12'S,14'aS,- 15'bR,17'aS,20'aS,20'bS,22'R,22'aS,22'bR)-
Dispiro[furan-2(3H),2'(13'H)-bisfuro[3'',2'':3',4']- cyclopenta[1',2':5,6]naphtho[1,2-b:1',2'-i]- phenazine-13',2''(3''H)-furan]-11',22'-diol,1',- 3'a,4,4',4'',4'a,4'b,5,5',5'',6',6'a,7',9',9'a,9'b,10',- 11',11'a,11'b,12',14'a,15',15'a,15'b,16',17',17'a,- 18',20',20'a,20'b,21',22',22'a,22'bhexatriacontahydro- 1',5,5,5'',5'',9'a,11'a,12',- 20'a,22'a-decamethyl-,(1'S,2R,2''S,3'aS,4'aR,- 4'bR,6'aS,9'aS,9'bS,11'R,11'aS,11'bR,12'S,- 14'aS,15'aR,15'bR,17'aS,20'aS,20'bS,22'R,22'aS,- 22'bR)-
1,2,5-trimethyl-5-(morpholin-4-ylmethyl)-4-phenylpiperidin-4-yl (2E)-3-phenylprop-2-enoate dihydrochloride
5-[(dimethylamino)methyl]-1,2,5-trimethyl-4-phenylpiperidin-4-yl (2E)-3-phenylprop-2-enoate dihydrochloride
5-[(dipropylamino)methyl]-1,2,5-trimethyl-4-phenylpiperidin-4-yl (2E)-3-phenylprop-2-enoate dihydrochloride
5-(azepan-1-ylmethyl)-1,2,5-trimethyl-4-phenylpiperidin-4-yl (2E)-3-phenylprop-2-enoate dihydrochloride
1/C16H14ClNO3/c1-10-6-12(17)7-11(15(10)19)8-18-9-21-16(20)13-4-2-3-5-14(13)18/h2-7,19H,8-9H2,1H
1/C13H9IO2/c15-13-11-8-4-5-9-12(11)14(16-13)10-6-2-1-3-7-10/h1-9
1/C22H28O6/c1-23-17-11-21(27-5)19(25-3)9-15(17)13-7-8-14(13)16-10-20(26-4)22(28-6)12-18(16)24-2/h9-14H,7-8H2,1-6H3/t13-,14